Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan for PPI-Refractory GERD
NCT07437768Enrolling by invitation
- Sponsor
- Fu Jen Catholic University Hospital
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vonoprazan in gastroesophageal reflux disease (GERD), sponsored by Fu Jen Catholic University Hospital. Primary endpoint: The GERD Questionnaire at 4 weeks. Started Dec 2025; status: enrolling by invitation.
02
Drugs
vonoprazan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT07437768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07437768.